3-trans-p-Coumaroylrotundic acid



Compound IDCDAMM01668
Common name3-trans-p-Coumaroylrotundic acid
IUPAC name1-hydroxy-9-(hydroxymethyl)-10-[3-(4-hydroxyphenyl)prop-2-enoyloxy]-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
Molecular formulaC39H54O7

Experimental data

Retention time3.86
Adduct[M+H]+
Actual mz635.396
Theoretical mz635.394
Error2.56
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.8723

Identifiers and class information

Inchi keyWSWPNGAODCKAHB-NTEUORMPNA-N
SmilesO=C(OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(O)(C)C(C)CCC5(C(=O)O)CCC43C)C1(C)CO)C=CC6=CC=C(O)C=C6
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)9
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)634.851
Computed dipole moment(dipole)7.991
Total solvent accessible surface area (SASA)908.084
Hydrophobic component of SASA (FOSA)509.015
Hydrophilic component of SASA (FISA)206.871
Pie component of the SASA (PISA)192.197
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1860.02
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)7.2
Free energy of solvation of dipole (dip^2/V)0.0343327
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0158576
Globularity descriptor (glob)0.805472
Predicted polarizability in cubic angstroms (QPpolrz)64.34
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.947
Predicted octanol/gas partition coefficient (QPlogPoct)32.231
Predicted water/gas partition coefficient (QPlogPw)15.584
Predicted octanol/water partition coefficient (QPlogPo/w)6.736
Predicted aqueous solubility (QPlogS)-8.169
Conformation-independent predicted aqueous solubility (CIQPlogS)-9.33
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.789
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)27.399
Predicted brain/blood partition coefficient (QPlogBB)-2.105
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)12.888
Predicted skin permeability, log Kp (QPlogKp)-3.791
PM3 calculated ionization potential (IP(ev))8.953
PM3 calculated electron affinity (EA(eV))0.554
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)1.497
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)66.204
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)136.295
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA
Q01064PDE1BPhosphodiesterase 1BT77613SEA
O43826SLC37A4Glucose-6-phosphate translocaseT47306SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T77613DI0265Mild neurocognitive disorder[ICD-11: 6D71]Q01064PDE1B

Copyright © 2025